The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex
Open accessAbstract
We investigated oxidative stress in human postmortem frontal cortexfrom individuals characterized as mild cognitive impairment (n= 8), mild/moderate Alzheimer disease (n = 4), and late-stage Alzheimer disease (n = 9). Samples from subjects with no cognitive impairment (n = 10) that were age- and postmortem interval-matched with these cases were used as controls. The short postmortem intervalbrain samples were processed for postmitochondrial supernatant, nonsynaptic mitochondria, and synaptosome fractions. Samples were analyzed for several antioxidants (glutathione, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, glucose-6-phosphate dehydrogenase, superoxide dismutase, catalase) and the oxidative marker, thiobarbituric acid reactive substances. The tissue was also analyzed for possible changes in protein damage using neurochemical markers for protein carbonyls, 3-nitrotyrosine, 4-hydroxynonenal, andacrolein. All 3 neuropil fractions (postmitochondrial supernatant, mitochondrial, and synaptosomal) demonstrated significant disease-dependent increases in oxidative markers. The highest changes were observed in the synaptosomal fraction. Both mitochondrial and synaptosomal fractions had significant declines in antioxidants (glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase). Levels of oxidative markers significantly correlated with Mini-Mental Status Examination scores. Oxidative stress was more localized to the synapses, with levels increasing in a disease-dependent fashion. These correlations implicate an involvement of oxidative stress in Alzheimer disease-related synaptic loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, TNT formation is often associated with oxidative stress, another key feature of AD [120,121,122].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [121]
Experimental — accuracy not yet measuredIn the citing paper
“3-nitrotyrosine and protein carbonyls, these last produced mainly by the action of free radicals on the peptide chain or by oxidation of amino acids, are used as biomarkers of oxidative damage in the brain of AD and MCI [18,24,31,32,33].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
In the citing paper
“In response to OS in the brain, a number of protective mechanisms are up regulated to maintain the oxidative balance, in particular compensatory induction of antioxidant enzymes such as superoxide dismutase, glutathione reductase, catalase have been found in vulnerable neurons in AD [31].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
In the citing paper
“Reduction of antioxidants such as glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase are demonstrated post-mortem in the mitochondrial and synaptosomal fractions in the frontal cortex of MCI and AD patients [31].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,871
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Cited by
Sorted by citations
Items 201–300 of 623
Wang, C., Zhang, Q., Xun, Z., Yuan, L., Li, R., Li, X., Tian, S.-Y., Xin, N., & Xu, Y. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101672 · Cited by 52
Fat-soluble vitamins in patients with chronic pancreatitis (pancreatic insufficiency).
Nakamura, T., Takebe, K., Imamura, K., Tando, Y., Yamada, N., Arai, Y., Terada, A., Ishii, M., Kikuchi, H., & Suda, T. (1996) · PubMed · Cited by 52
Enns, G. M., Moore, T., Le, A. T., Atkuri, K. R., Shah, M. K., Cusmano‐Ozog, K. P., Niemi, A., & Cowan, T. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100001 · Cited by 49
He, B., Xu, F., Xiao, F., Yan, T., Wu, B., Bi, K., & Jia, Y. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0154-6 · Cited by 51
In Vivo Brain GSH: MRS Methods and Clinical Applications
Bottino, F., Lucignani, M., Napolitano, A., Dellepiane, F., Visconti, E., Rossi Espagnet, M. C., & Pasquini, L. (2021) · Antioxidants · doi:10.3390/antiox10091407 · Cited by 50
Insight into the potential role of ferroptosis in neurodegenerative diseases
Ji, Y., Zheng, K., Li, S., Ren, C., Shen, Y., Tian, L., Zhu, H., Zhou, Z., & Jiang, Y. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1005182 · Cited by 53
Ye, B. S., Lee, W., Ham, J. H., Lee, J. J., Lee, P. H., Sohn, Y. H., & Initiative, T. A. D. N. (2016) · European Journal of Neurology · doi:10.1111/ene.12969 · Cited by 51
Zolochevska, O., & Taglialatela, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160518142110 · Cited by 49
Anwar, M. M. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3673 · Cited by 54
Kuntić, M., Hahad, O., Münzel, T. F., & Daiber, A. (2024) · Antioxidants · doi:10.3390/antiox13030266 · Cited by 53
Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer’s Disease?
Murphy, K. E., & Park, J. C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061168 · Cited by 49
Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability
Uddin, M. S., & Kabir, M. T. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_5 · Cited by 50
Potential Role of Fluoride in the Etiopathogenesis of Alzheimer’s Disease
Goschorska, M., Baranowska‐Bosiacka, I., Gutowska, I., Metryka, E., Skórka-Majewicz, M., & Chlubek, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123965 · Cited by 48
Zafeer, M. F., Firdaus, F., Anis, E., & Hossain, M. S. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.04.006 · Cited by 48
Fonteh, A. N., Cipolla, M., Chiang, A. J., Edminster, S. P., Arakaki, X., & Harrington, M. G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00083 · Cited by 47
Wu, L., Xian, X., Tan, Z., Dong, F., Xu, G., Zhang, M., & Zhang, F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03245-7 · Cited by 51
da Cunha, F. M., Demasi, M., & Kowaltowski, A. J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.035 · Cited by 47
Kassaar, O., Morais, M. P. P., Xu, S., Adam, E. L., Chamberlain, R. C., Jenkins, B., James, T. D., Francis, P. T., Ward, S. G., Williams, R. J., et al. (2017) · Scientific Reports · doi:10.1038/srep42874 · Cited by 49
Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention
Schelke, M. W., Attia, P., Palenchar, D. J., Kaplan, B., Mureb, M., Ganzer, C. A., Scheyer, O., Rahman, A., Kachko, R., Krikorian, R., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00096 · Cited by 52
Walia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02617-1 · Cited by 47
Molecular Targets in Alzheimer’s Disease
Bjørklund, G., Aaseth, J., Dadar, M., & Chirumbolo, S. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1563-9 · Cited by 48
Rapaka, D., Bitra, V., Vishala, T. C., & Akula, A. (2018) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2017.06.013 · Cited by 34
Kommaddi, R. P., Tomar, D. S., Karunakaran, S., Bapat, D., Nanguneri, S., Ray, A., Schneider, B. L., Nair, D. K., & Ravindranath, V. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7754 · Cited by 44
The promising role of natural products in Alzheimer's disease
da Rosa, M. M., de Amorim, L. C., Alves, J. V. D. O., Aguiar, I. F. D. S., Oliveira, F. G. D. S., da Silva, M. V., & dos Santos, M. T. C. (2022) · Brain Disorders · doi:10.1016/j.dscb.2022.100049 · Cited by 53
Glutathione System and Oxidative Stress in Health and Disease
Bagatini, M. D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82965 · Cited by 48
Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes?
Staurenghi, E., Giannelli, S., Testa, G., Sottero, B., Leonarduzzi, G., & Gamba, P. (2021) · Antioxidants · doi:10.3390/antiox10121890 · Cited by 44
Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer’s Disease
Paul, B. D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.659402 · Cited by 42
Shen, Y., Zhang, G., Wei, C., Zhao, P., Wang, Y., Li, M., & Sun, L. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01343 · Cited by 44
Oxidative stress and chronic cerebral hypoperfusion: An overview from preclinical rodent models
Kimura, S., Iwata, M., Takase, H., Lo, E. H., & Arai, K. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241305899 · Cited by 44
The neurotoxic effect of astrocytes activated with toll-like receptor ligands
Ma, D., Jin, S., Li, E., Doi, Y., Parajuli, B., Noda, M., Sonobe, Y., Mizuno, T., & Suzumura, A. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.08.010 · Cited by 44
Adav, S. S., & Sze, S. K. (2020) · Aging and Disease · doi:10.14336/ad.2019.0604 · Cited by 44
Neuroprotective Effect of Terpenoids Recovered from Olive Oil By-Products
Montenegro, Z. J. S., Álvarez‐Rivera, G., Sánchez-Martínez, J. D., Gallego, R., Valdés, A., Bueno, M., Cifuentes, A., & Ibáñez, E. (2021) · Foods · doi:10.3390/foods10071507 · Cited by 43
Mitochondria and Cellular Redox State on the Route from Ageing to Alzheimer's Disease
Abate, G., Vezzoli, M., Sandri, M., Rungratanawanich, W., Memo, M., & Uberti, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111385 · Cited by 41
Protein aggregation into insoluble deposits protects from oxidative stress
Čarija, A., Navarro, S., de Groot, N. S., & Ventura, S. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.027 · Cited by 42
Yang, E.-J., Mahmood, U., Kim, H.-J., Choi, M., Choi, Y., Lee, J., Cho, J., Hyun, J. W., Kim, Y. S., Chang, M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.016 · Cited by 42
Lan, J., Zeng, R., Jiang, X., Hou, J., Liu, Y., Hu, Z.-H., Li, H., Li, Y., Xie, S., Ding, Y., et al. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103413 · Cited by 41
Serum Uric Acid, Alzheimer-Related Brain Changes, and Cognitive Impairment
Kim, J. W., Byun, M. S., Yi, D., Lee, J. H., Jeon, S. Y., Ko, K., Jung, G., Lee, H. N., Lee, J., Sohn, C., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00160 · Cited by 41
N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases
Martínez, M. (2022) · Antioxidants · doi:10.3390/antiox11020416 · Cited by 46
Natural antioxidants in prevention and management of Alzheimer s disease
Zhao, B. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e419 · Cited by 41
Sultana, R., Robinson, R. A. S., Di Domenico, F., Abdul, H. M., Clair, D. K. S., Markesbery, W. R., Cai, J., Pierce, W. M., & Butterfield, D. A. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.06.015 · Cited by 41
Kastman, E. K., Willette, A. A., Coe, C. L., Bendlin, B. B., Kosmatka, K. J., McLaren, D. G., Xu, G., Canu, E., Field, A. S., Alexander, A. L., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2553-12.2012 · Cited by 40
Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease
Adalier, N., & Parker, H. (2016) · Antioxidants · doi:10.3390/antiox5040040 · Cited by 40
Afsar, A., Castro, M. D. C. C., Soladogun, A. S., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087258 · Cited by 45
Kim, H. J., Jang, B. K., Park, J., Choi, J., Park, S. J., Byeon, S. R., Pae, A. N., Lee, Y. S., Cheong, E., & Park, K. D. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111777 · Cited by 40
Li, Z., Bi, H. C., Jiang, H., Song, J., Meng, Q., Zhang, Y., & Fei, X. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11747 · Cited by 40
Babaei, P., Eyvani, K., & Kouhestani, S. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03289-y · Cited by 42
Ekundayo, B. E., Obafemi, T. O., Afolabi, B. A., Adewale, O. B., Onasanya, A., Osukoya, O. A., Falode, J. A., Akintayo, C. O., & Adu, I. A. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2022.100193 · Cited by 43
Nagata, Y., Hirayama, A., Ikeda, S., Shirahata, A., Shoji, F., Maruyama, M., Kayano, M., Bundo, M., Hattori, K., Yoshida, S., et al. (2018) · Biomarker Research · doi:10.1186/s40364-018-0119-x · Cited by 42
Relation of Plasma Selenium and Lipid Peroxidation End Products in Patients With Alzheimer’s Disease
Chmátalová, Z., Vyhnálek, M., Laczó, J., Hort, J., POSPISILOVA, R., Pechová, M., & Skoumalová, A. (2017) · Physiological Research · doi:10.33549/physiolres.933601 · Cited by 39
Recent Progress in Autocatalytic Ceria Nanoparticles-Based Translational Research on Brain Diseases
Choi, S. W., & Kim, J. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b02243 · Cited by 39
The Dying of the Light: Mitochondrial Failure in Alzheimer's Disease
Young, K. J., McArdle, M. J., & Bennett, J. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111487 · Cited by 39
CNS Redox Homeostasis and Dysfunction in Neurodegenerative Diseases
Goldsteins, G., Hakosalo, V., Jaronen, M., Keuters, M. H., Lehtonen, Š., & Koıstınaho, J. (2022) · Antioxidants · doi:10.3390/antiox11020405 · Cited by 42
Neurodegenerative Microbially-Shaped Diseases: Oxidative Stress Meets Neuroinflammation
Silva, D. F., Empadinhas, N., Cardoso, S. M., & Esteves, A. R. (2022) · Antioxidants · doi:10.3390/antiox11112141 · Cited by 44
Song, R., Yin, S., Wu, J., & Yan, J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00025 · Cited by 41
de Oliveira, J. S., Abdalla, F. H., Dornelles, G. L., Palma, T. V., Signor, C., Bernardi, J., Baldissarelli, J., Lenz, L. S., de Oliveira, V. A., Schetinger, M. R. C., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5090-6 · Cited by 38
Voluntary exercise counteracts Aβ25-35-induced memory impairment in mice
Wang, Q. L., Xu, Z., Tang, J., Sun, J., Gao, J., Wu, T., & Xiao, M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.09.024 · Cited by 39
One‐pot Synthesis of Novel Spirooxindoles as Antibacterial and Antioxidant Agents
El-Hashash, M. A. A., & Rizk, S. A. (2016) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.2758 · Cited by 37
Alzheimer's Disease and NQO1: Is there a Link?
Chhetri, J., King, A. E., & Gueven, N. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170203095802 · Cited by 38
Izumi, H., Sato, K., Kojima, K., Saito, T., Saido, T. C., & Fukunaga, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108026 · Cited by 37
Protto, V., Tramutola, A., Fabiani, M., Marcocci, M. E., Napoletani, G., Iavarone, F., Vincenzoni, F., Castagnola, M., Perluigi, M., Di Domenico, F., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8070972 · Cited by 36
Lan, X.-Y., Sun, Z., Xu, G., Chu, C., Qin, H., Li, S., Geng, X., Gao, P., Boltze, J., & Li, S. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10178-y · Cited by 38
Zhao, Y., Ye, F., Xu, J., Liao, Q., Chen, L., Zhang, W., Sun, H., Liu, W., Feng, F., & Qu, W. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.06.018 · Cited by 37
Do glutathione and copper interact to modify Alzheimer's disease pathogenesis?
Ho, T., Ahmadi, S., & Kerman, K. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.01.025 · Cited by 37
Striking a NRF2: The Rusty and Rancid Vulnerabilities Toward Ferroptosis in Alzheimer's Disease
Lane, D. J. R., Alves, F. M., Ayton, S., & Bush, A. I. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0318 · Cited by 36
Persichilli, S., Gervasoni, J., Napoli, A. D., Fuso, A., Nicolia, V., Giardina, B., Scarpa, S., Desiderio, C., & Cavallaro, R. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142391 · Cited by 37
Wang, Y., Wang, Y., Bharti, V., Zhou, H., Hoi, V., Tan, H. T., Wu, Z., Nagakannan, P., Eftekharpour, E., & Wang, J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190223 · Cited by 37
Zhang, Y., & Kiryu, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-34021-1 · Cited by 37
H2O2 and PAF mediate Aβ1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761
Shi, C., Wu, F., & Xu, J. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.016 · Cited by 35
The use of magnetic resonance spectroscopy for assessing the effect of diet on cognition
Scavuzzo, C. J., Moulton, C. J., & Larsen, R. J. (2016) · Nutritional Neuroscience · doi:10.1080/1028415x.2016.1218191 · Cited by 35
Kantar, D., Hidişoğlu, E., Ocak, G. A., Er, H., Acun, A. D., & Yargıçoğlu, P. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.04.008 · Cited by 34
Oskouei, Z., Mehri, S., Kalalinia, F., & Hosseinzadeh, H. (2020) · Phytotherapy Research · doi:10.1002/ptr.6982 · Cited by 34
Natural antioxidants in prevention and management of Alzheimer's disease
Zhao, Y. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/419 · Cited by 35
Murotomi, K., Takagi, N., Takeo, S., & Tanonaka, K. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.01.009 · Cited by 35
Singh, M., & Silakari, O. (2016) · RSC Advances · doi:10.1039/c6ra17678j · Cited by 34
Therapeutic Potential of Vitamin D and Curcumin in an In Vitro Model of Alzheimer Disease
Alamro, A. A., Alsulami, E., Almutlaq, M., Alghamedi, A., Alokail, M. S., & Haq, S. H. (2020) · Journal of Central Nervous System Disease · doi:10.1177/1179573520924311 · Cited by 35
Khan, S., Khan, H. U., Khan, F. A., Shah, A., Wadood, A., Ahmad, S., Almehmadi, M. M., Alsaiari, A. A., Shah, F. U., & Kamran, N. (2022) · Pharmaceuticals · doi:10.3390/ph15101205 · Cited by 37
Izuo, N., Kume, T., Sato, M., Murakami, K., Irie, K., Izumi, Y., & Akaike, A. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300033k · Cited by 34
(−)-Epicatechin mitigates high fat diet-induced neuroinflammation and altered behavior in mice
Kang, J., Wang, Z., & Oteiza, P. I. (2020) · Food & Function · doi:10.1039/d0fo00486c · Cited by 35
Changes in Biothiol Levels Are Closely Associated with Alzheimer’s Disease
Han, H., Wang, F., Chen, J., Li, X., Fu, G., Zhou, J., Zhou, D., Wu, W., & Chen, H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210021 · Cited by 33
Future of Alzheimer’s Disease: Nanotechnology-Based Diagnostics and Therapeutic Approach
Agraharam, G., Saravanan, N., Girigoswami, A., & Girigoswami, K. (2022) · BioNanoScience · doi:10.1007/s12668-022-00998-8 · Cited by 36
Karapetyan, G., Fereshetyan, K., Harutyunyan, H. A., & Yenkoyan, K. B. (2022) · Scientific Reports · doi:10.1038/s41598-022-22761-5 · Cited by 36
Frontiers in Alzheimer’s disease therapeutics
Stone, J. G., Casadesús, G., Rothenberg, K. G., Siedlak, S. L., Wang, X., Zhu, X., Perry, G. L., Castellani, R. J., & Smith, M. A. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310382817 · Cited by 32
Uddin, M. S. (2016) · American Journal of Psychiatry and Neuroscience · doi:10.11648/j.ajpn.20160402.12 · Cited by 32
Madrid, L., Initiative, A. D. N., Moreno–Grau, S., Ahmad, S., González-Pérez, A., de Rojas, I., Xia, R., Adami, P. V. M., García‐González, P., Kleineidam, L., et al. (2021) · Aging · doi:10.18632/aging.202950 · Cited by 33
Topkara, K. Ç., Kılınç, E., Çetinkaya, A., Şaylan, A., & Demír, Ş. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15565 · Cited by 33
A Multi-Center Study on Human Brain Glutathione Conformation using Magnetic Resonance Spectroscopy
Shukla, D., Mandal, P. K., Ersland, L., Grüner, E. R., Tripathi, M., Raghunathan, P., Sharma, A., Radhakrishna, C. G., Punjabi, K., & Splaine, C. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180648 · Cited by 32
In vitro cholinesterase inhibitory and antioxidant effect of selected coniferous tree species
Şenol, F. S., Orhan, İ. E., & Ustun, O. (2015) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60329-1 · Cited by 32
Simpson, T. N., Kure, C., & Stough, C. K. K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00694 · Cited by 31
Chen, Y., Li, Q., Jiang, H., & Wang, X. (2016) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2016.06.020 · Cited by 31
Tobore, T. O. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181052 · Cited by 32
Anticancer Activity of Astaxanthin-Incorporated Chitosan Nanoparticles
Hwang, E. J., Jeong, Y., Lee, K.-J., Yu, Y.-B., Ohk, S., & Lee, S. (2024) · Molecules · doi:10.3390/molecules29020529 · Cited by 28
Small Molecule Natural Products and Alzheimer’s Disease
Wu, X., Cai, H., Pan, L., Cui, G., Qin, F., Li, Y., & Cai, Z. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190201153257 · Cited by 29
Wang, Y., Guo, W., Xie, S., Liu, Y., Xu, D., Chen, G., & Xu, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114280 · Cited by 30
Monjas, L., Arce, M. P., Leon, R. M., Egea, J., Pérez, C., Villarroya, M., López, M. G., Gil, C., Conde, S., & Rodrı́guez-Franco, M. I. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.02.034 · Cited by 30
Lane, H., Wang, S., & Lin, C. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13504 · Cited by 28
Legleiter, J. A., Fryer, J. D., Holtzman, D. M., & Kowalewski, T. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn2000475 · Cited by 28
Increased hippocampal quinone reductase 2 in Alzheimer's disease
Hashimoto, T., & Nakai, M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.008 · Cited by 29
Association of Anterior Cingulate Glutathione with Sleep Apnea in Older Adults At-Risk for Dementia
Duffy, S. L., Lagopoulos, J., Terpening, Z., Lewis, S. J. G., Grunstein, R. R., Mowszowski, L., Cross, N. E., Hermens, D. F., Hickie, I. B., & Naismith, S. L. (2016) · SLEEP · doi:10.5665/sleep.5650 · Cited by 28
Alipourfard, F., Shajiee, H., Nazari-Serenjeh, F., Hojati, V., & Alirezaie, M. (2023) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.371583 · Cited by 29
Lv, C., Ma, Q., Han, B., Li, J., Geng, Y., Zhang, X., & Wang, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00200 · Cited by 28
Metadata
- Authors
- Ansari, M. A., & Scheff, S. W.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Scheff, Stephen W.
- ORCID
- Ansari, Mubeen A.
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02
- Volume
- 69
- Issue
- 2
- Pages
- 155-167
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- PMC
- PMC2826839
- OpenAlex
- W2031762170
- Cited by
- 605
- References
- 96
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 44 · 2023: 40 · 2022: 51 · 2021: 56 · 2020: 44 · 2019: 38 · 2018: 30 · 2017: 31 · 2016: 41 · 2015: 29 · 2014: 31 · 2013: 24 · 2012: 31
- FWCI
- 21.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG-028383, AG27219, P30AG028383, P01AG014449, R01AG043375, R01AG027219)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, Alzheimer's disease, frontal cortex, synaptosomes, mitochondria, antioxidants, glutathione, superoxide dismutase, lipid peroxidation, protein carbonyls, nitrotyrosine, 4-hydroxynonenal, acrolein, synaptic loss, disease progression, mild cognitive impairment, postmortem brain
- MeSH terms
- Aged, Aged, 80 and over, Aldehydes, Alzheimer Disease, Antioxidants, Female, Frontal Lobe, Humans, Male, Mental Status Schedule, Synapses, Tissue Distribution, Tyrosine, Biomarkers, Thiobarbituric Acid Reactive Substances, Oxidative Stress, Disease Progression, Protein Carbonylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
